Stock Code: 002653 Stock Abbreviation: Haisco Listing Venue: Shenzhen Stock Exchange
Haisco Pharmaceutical Group Co., Ltd.
2025 Report on Issuance of A-Shares to Specific Targets
Sponsor (Lead Underwriter): CITIC Securities Company Limited
July 2026
Statement of All Directors and Senior Management of the Company
All directors and senior management of the Company guarantee that this issuance report does not contain any false records, misleading statements, or material omissions, and assume joint and several legal liability for its authenticity, accuracy, and completeness.
Signatures of all directors:
Wang Junmin: [blank]
Yan Pangke: [blank]
Cao Chuande: [blank]
Yue Lin: [blank]
Le Jun: [blank]
Xu Binglun: [blank]
Date: [blank]
Signatures of senior management other than directors:
Wang Meng: [blank]
Duan Peng: [blank]
Wang Ruibin: [blank]
Table of Contents
-
Company Directors and Senior Management Statement
-
Table of Contents
-
Definitions
-
Section I: Basic Information on the Issuance
-
I. Relevant procedures performed for this issuance
-
II. Overview of this issuance
-
III. Overview of the issuance targets
-
IV. Information on institutions related to this issuance
- Section II: Comparison of Conditions Before and After the Issuance
-
I. Changes in the top ten shareholders before and after the issuance
-
II. Impact of the issuance on the listed company
- Section III: Conclusion of the Sponsor (Lead Underwriter) on the Compliance of the Issuance Process and Targets
-
I. Conclusion on the compliance of the pricing process
-
II. Opinion on the compliance of the selection of issuance targets
-
Section IV: Conclusion of the Issuer's Counsel on the Compliance of the Issuance Process and Targets
-
Section V: Statement of Intermediary Agencies
-
Section VI: Documents Available for Inspection
-
I. List of documents available for inspection
-
II. Access method
Definitions
In this report, unless the context otherwise requires, the following abbreviations have the following meanings:
| Abbreviation | Definition |
|---|---|
| Company/Listed Company/Issuer/Haisco | Haisco Pharmaceutical Group Co., Ltd. |
| Articles of Association | Articles of Association of Haisco Pharmaceutical Group Co., Ltd. |
| This Issuance/Issuance to Specific Targets | Haisco Pharmaceutical Group Co., Ltd. 2025 Issuance of A-Shares to Specific Targets |
| This Issuance Report | Haisco Pharmaceutical Group Co., Ltd. 2025 Report on Issuance of A-Shares to Specific Targets |
| Issuance and Underwriting Plan | Issuance and Underwriting Plan for A-Shares to Specific Targets of Haisco Pharmaceutical Group Co., Ltd. |
| Sponsor (Lead Underwriter) | CITIC Securities Company Limited |
| Issuer's Counsel | Beijing Zhong Lun Law Firm |
| Audit Institution/Issuer's Accountant/Capital Verification Institution | ShineWing Certified Public Accountants (Special General Partnership) |
| A-Share | Domestically listed RMB-denominated ordinary shares |
| CSRC | China Securities Regulatory Commission |
| SZSE | Shenzhen Stock Exchange |
| Company Law | Company Law of the People's Republic of China |
| Securities Law | Securities Law of the People's Republic of China |
| Registration Measures | Administrative Measures for Securities Issuance and Registration of Listed Companies |
| Underwriting Measures | Administrative Measures for Securities Issuance and Underwriting |
| Implementation Rules | Implementation Rules for Securities Issuance and Underwriting of Listed Companies on the Shenzhen Stock Exchange |
| Yuan, Ten Thousand Yuan | RMB Yuan, RMB Ten Thousand Yuan |
| Subscription Quotation Sheet | Subscription Quotation Sheet for A-Shares to Specific Targets of Haisco Pharmaceutical Group Co., Ltd. |
| Subscription Invitation Letter | Subscription Invitation Letter for A-Shares to Specific Targets of Haisco Pharmaceutical Group Co., Ltd. |